As of 2024-12-03, the Fair Value of bluebird bio Inc (BLUE) is -10.84 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.41 USD, the upside of bluebird bio Inc is -2,776.74%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
Historical Earnings | ||||||
2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
Net income | -789.61 | -618.70 | -819.38 | -266.58 | -211.91 | -541.24 |
YoY growth | -42.11% | 21.64% | -32.44% | 67.47% | 20.51% | 7.01% |
Market Cap (mil) | 78.75 |
P/E | |
Forward P/E |
EPS | -1.55 |
Avg earnings growth rate | 7.01% |
TTM earnings | -300.52 |